Rallybio Corporation RLYB
Super Investor & Insider
1
Fondi che lo detengono
#1173
Rank consenso
1.4%
% dei portafogli
$4.7M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Viking Global Investors · Viking Global Investors | 0.01% | Buy | 524,347 | $4.7M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Rallybio Corporation is a biopharmaceutical company focusing on the development and commercialization of transformative therapies for severe and rare diseases. The company's primary purpose is to harness scientific advancements to address unmet medical needs, targeting life-threatening conditions that often lack effect…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees14
TickerRLYB
Statistics
Market Cap$84.9M
Revenue (TTM)$858000
Net Income-$9.0M
Net Margin-1046.4%
EPS$-1.59
P/E-10.05
P/S107.62
P/B1.68
EV/EBITDA-1.25
ROE-15.0%
Dividend Yield—
Price$16.04
Data: Twelve Data · Revenue = mcap / P/S